All News

Two researchers work together in a laboratory while wearing masks.
|
Research Feature
An ancient part of the immune system could advance heart disease research
A cell-based look at how the body responds to immune threats may one day help researchers find better treatments for this major U.S. killer For more than a decade, researchers have known that a core component of human immune function – called complement – can influence how the body responds to immune threats. Now researchers from the NIH and around...
Filter by keyword

ADD OTHER FILTERS

Filter by

News Type
Topic
Language
Published Date

Filter by News Type

Done

Filter by Topic

Done

Filter by Language

Done

Filter by Published Date

Done
Showing 10 out of 344 results
COVID-19 patient in the intensive care unit
|
Statement
NIH ACTIV trial of blood thinners pauses enrollment of critically ill COVID-19 patients
Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients. Among critically ill COVID-19 patients requiring intensive care unit (ICU) support, therapeutic anticoagulation drugs did not reduce the need for organ support...
collage of pictures of diverse people
|
Research Features
Community engagement builds needed trust in science and scientists
When the November 2020 news broke that two vaccines had proven to be highly effective in preventing COVID-19 or minimizing its impact, people everywhere began talking about seeing a light at the end of the tunnel. But many public health experts were talking, too, about another bright spot – the vast numbers of participants from racial and ethnic...
Health care provider prepares to inject patient with influenza vaccine. Image credit: Shutterstock.
|
News Release
High-dose influenza vaccine shows no additional benefit for heart disease patients
NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group High-dose influenza (commonly known as flu) vaccines are no better than regular-dose influenza vaccines in reducing deaths and hospitalizations among patients with underlying heart disease, according to a large study publishing in...
Girl with pinwheel
|
News Release
New updates to federal guidelines revamp asthma management
Updates to six key areas of asthma care focus on improving diagnosis, management and treatment The National Institutes of Health today announced 19 recommendations in six key areas of asthma diagnosis, management and treatment. The new guidance, published in the Journal of Allergy and Clinical Immunology, represents the first updates to federal...
headshot of Dr. Marishka Brown
|
Media Advisory
The National Heart, Lung, and Blood Institute Names Marishka Brown, Ph.D., Director of the National Center on Sleep Disorders Research
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces selection of Marishka Brown, Ph.D., as Director of the National Center on Sleep Disorders Research (NCSDR). Congress established the NCSDR in 1993 to coordinate sleep research throughout NIH and other federal agencies. Dr. Brown succeeds Michael Twery, Ph.D., who served as the...
Console for control extracorporeal membrane oxygenation (ECMO) machine that replicates the functions of the heart and lungs includes knob, buttons and displays
|
News Release
Cardiac arrest treatment that uses life support machine boosts survival
Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet. The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so...
Creative rendition of SARS-CoV-2 virus particles.
|
News Release
Hydroxychloroquine does not benefit adults hospitalized with COVID-19
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
Illustration shows components of the lysosome exocytosis pathway, which coronaviruses use to exit cells. Also shown are components of the normal biosynthetic secretory pathway.
Credit: Courtesy of NIH Medical Arts
|
News Release
NIH scientists discover key pathway in lysosomes that coronaviruses use to exit cells
Targeting cell’s ‘trash compactor’ could lead to new antiviral strategy to fight COVID-19 Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body. A better understanding of this important pathway may provide vital insight...
Paciente y doctor leyendo reportes en un hospital
|
News Release
Los NIH financian estudios sobre participación comunitaria para reducir impacto de la COVID-19 en las comunidades más afectadas
Los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) anunciaron hoy una subvención de $12 millones para proyectos de promoción de salud y participación comunitaria en regiones con minorías étnicas y raciales afectadas de manera desproporcionada por la pandemia de COVID-19. Con estos fondos, RTI International, una institución de...
doctor reviewing paperwork with his patient who is reading along.
|
News Release
NIH funds community engagement research efforts in areas hardest hit by COVID-19
The National Institutes of Health today announced a $12 million award for outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic. The award to RTI International, a non-profit research institution, will support teams in 11 states established as part of the NIH Community...